Network Meta-Analysis of Angiogenesis Inhibitors on Survival of Patients with Small Cell Lung Cancer

被引：1
|
作者：
Shi, X. [1 ]
Liu, X. [1 ]
Wang, Y. [2 ]
Lu, D. [1 ]
Dong, X. [1 ]
Feng, S. [1 ]
Cai, K. [1 ]
机构：
[1] Nanfang Hosp, Thorac Surg, Guangzhou, Guangdong, Peoples R China
[2] Nanfang Hosp, Oncol, Guangzhou, Guangdong, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
small cell lung cancer; survival; Angiogenesis Inhibitors;
D O I：
10.1016/j.jtho.2018.08.1384
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.12-08
引用
收藏
页码：S793 / S793
页数：1
相关论文
共 50 条
  • [41] Adjuvant EGFR tyrosine kinase inhibitors for patients with resected EGFR-mutated non-small-cell lung cancer: a network meta-analysis
    Tian, Wentao
    Tan, Nuopei
    Ke, Jiawen
    Zou, Ji'an
    Liu, Xiaohan
    Pan, Yue
    Zeng, Yue
    Peng, Yurong
    Wu, Fang
    FUTURE ONCOLOGY, 2022, 18 (21) : 2695 - 2708
  • [42] Erlotinib in patients with advanced non-small-cell lung cancer: a meta-analysis
    Gao, Hui
    Ding, Xin
    Wei, Dong
    Cheng, Peng
    Su, Xiaomei
    Liu, Huanyi
    Aziz, Fahad
    Wang, Daoyuan
    Zhang, Tao
    TRANSLATIONAL LUNG CANCER RESEARCH, 2012, 1 (02) : 129 - 144
  • [43] Assessing the relative effectiveness and tolerability of treatments in small cell lung cancer: A network meta-analysis
    Bakalos, Georgios
    Miligkos, Michael
    Doxani, Chrysoula
    Mpoulimari, Ioanna
    Rodopoulou, Paraskevi
    Zintzaras, Elias
    CANCER EPIDEMIOLOGY, 2013, 37 (05) : 675 - 682
  • [44] Angiogenesis inhibitors in the treatment of small cell and non-small cell lung cancer
    Blackhall, FH
    Shepherd, FA
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2004, 18 (05) : 1121 - +
  • [45] Thyroid Dysfunction in Non-Small Cell Lung Cancer With Immune Checkpoint Inhibitors: A Meta-Analysis
    Lin, Lanlan
    Yang, Fan
    Lin, Guofu
    Chen, Xiangqi
    JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (02): : 210 - 218
  • [46] Checkpoint inhibitors as dual immunotherapy in advanced non-small cell lung cancer: a meta-analysis
    Alifu, Muyesar
    Tao, Min
    Chen, Xiao
    Chen, Jie
    Tang, Kejing
    Tang, Yubo
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [47] Immune checkpoint inhibitors for treatment of small-cell lung cancer: a systematic review and meta-analysis
    Niu, Zhicheng
    Guo, Shenghu
    Cao, Jing
    Zhang, Yuehua
    Guo, Xiaojin
    Grossi, Francesco
    Ichiki, Yoshinobu
    Li, You
    Wang, Zhiyu
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (08)
  • [48] SURVIVAL ANALYSIS OF PATIENTS WITH SMALL CELL LUNG-CANCER
    SERDENGECTI, S
    BUYUKUNAL, E
    MOLINAS, N
    DEMIRELLI, FH
    BERKARDA, N
    EYUBOGLU, H
    DERMAN, U
    BERKARDA, B
    CHEMIOTERAPIA, 1988, 7 (02): : 117 - 121
  • [49] Efficacy and safety of programmed death 1 inhibitors in patients with advanced non-small cell lung cancer: a meta-analysis
    Liu, Yi
    Zhou, Sijing
    Du, Yongsheng
    Sun, Li
    Jiang, Huihui
    Zhang, Binbin
    Sun, Gengyun
    Wang, Ran
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 4619 - 4630
  • [50] The prognostic significance of diabetes in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis
    Nguyen, Nam Nhat
    Nguyen, Thu Huynh Ha
    Hoang, Kinh Dinh
    Vo, Thai Kien
    Pham, Quan Hoang Minh
    Chen, Yang Ching
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 218
12345